| |
 |
|
Class Information
Number: 514/178
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system > Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein one nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen through a double bond and wherein another nuclear carbon atom of said cyclopentanohydrophenanthrene is bonded to at least one other oxygen through a single bond as, e.g., ether, hydroxy or alcoholate, etc.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5124392 |
Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
Jun. 23, 1992 |
| 5120723 |
Method, compositions, and compounds for modulating brain excitability |
Jun. 9, 1992 |
| 5112815 |
9.alpha.-hydroxy-3-oxo-4,24(25)-stigmastadien-26-oic acid derivatives, a process for preparing same and pharmaceutical compositions containing same |
May. 12, 1992 |
| 5110810 |
Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation |
May. 5, 1992 |
| 5108991 |
Vehicle composition containing 1-substituted azacycloalkan-2-ones |
Apr. 28, 1992 |
| 5106963 |
Phospholipid conjugates and their preparation |
Apr. 21, 1992 |
| 5089488 |
.beta.-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same |
Feb. 18, 1992 |
| 5064822 |
Novel 3-keto-19-nor-.DELTA..sup.4,9 -steroids |
Nov. 12, 1991 |
| 5061700 |
Glyceryl acetate ointment vehicles |
Oct. 29, 1991 |
| 5053403 |
Methods for treatment of male-pattern baldness |
Oct. 1, 1991 |
| 5051261 |
Method for preparing a solid sustained release form of a functionally active composition |
Sep. 24, 1991 |
| 5047244 |
Mucoadhesive carrier for delivery of therapeutical agent |
Sep. 10, 1991 |
| 5043332 |
Novel 11.beta.-substituted -19-nor-steriods |
Aug. 27, 1991 |
| 5041434 |
Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application |
Aug. 20, 1991 |
| 5041432 |
Steroid derivatives useful as hypocholesterolemics |
Aug. 20, 1991 |
| 5037817 |
Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- |
Aug. 6, 1991 |
| 5032586 |
7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase |
Jul. 16, 1991 |
| 5026692 |
Use of sex hormone |
Jun. 25, 1991 |
| 5017568 |
Steriod 5-alpha-reductase inhibitors |
May. 21, 1991 |
| 5010071 |
Androstane derivatives |
Apr. 23, 1991 |
| 5006517 |
Treatment of Prader-Willi syndrome |
Apr. 9, 1991 |
| 5002940 |
Solid drug formulations and stable suspensions |
Mar. 26, 1991 |
| 5001119 |
16-substituted androstanes and 16-substituted androstenes |
Mar. 19, 1991 |
| 5001116 |
Inhibition of angiogenesis |
Mar. 19, 1991 |
| 4997827 |
Compositions containing 5-.alpha.-dihydro-19-norethisterone and derivatives thereof for in vivo inhibition of aromatase |
Mar. 5, 1991 |
| 4997826 |
Tetrahydrocortisol in glaucoma therapy |
Mar. 5, 1991 |
| 4994443 |
Inhibition of angiogenesis |
Feb. 19, 1991 |
| 4988684 |
Novel 4-alkylthio-steroids |
Jan. 29, 1991 |
| 4987128 |
Novel 10.beta.-alkynyl-steroids |
Jan. 22, 1991 |
| 4978532 |
Dosage form for administration of dehydroepiandrosterone |
Dec. 18, 1990 |
| 4978658 |
Compositions containing 5.alpha.-dihydro-19-norethisterone and derivatives thereof for in vivo inhibition of aromatase |
Dec. 18, 1990 |
| 4970205 |
Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-.alpha.-reductase |
Nov. 13, 1990 |
| 4966897 |
4-substituted 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds useful as C17-20 lyase inhibitors |
Oct. 30, 1990 |
| 4956357 |
Biological methods utilizing dihydrotestosterone heptanoate |
Sep. 11, 1990 |
| 4956355 |
Agents for the arrest and therapy of retroviral infections |
Sep. 11, 1990 |
| 4948790 |
Long-acting androgenic compounds and pharmaceutical compositions thereof |
Aug. 14, 1990 |
| 4945064 |
Estrane and androstane derivatives, process for producing them and preparations containing these compounds |
Jul. 31, 1990 |
| 4942031 |
Compositions containing LYCD and other topically active medicinal ingredients |
Jul. 17, 1990 |
| 4937238 |
Prevention of mammary carcinoma |
Jun. 26, 1990 |
| 4925834 |
3-methylene-4-androsten-17-ones, process for their production and pharmaceutical preparations containing them |
May. 15, 1990 |
| 4923640 |
Process for the production of 17.alpha.-ethinyl-17.beta.-hydroxy-18-methyl-4,15-estradien-3-one and new intermediate products for this process |
May. 8, 1990 |
| 4920115 |
Method of lowering LDL cholesterol in blood |
Apr. 24, 1990 |
| 4910191 |
19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
Mar. 20, 1990 |
| 4908358 |
Inhibition of immune clearance using progesterone analogues |
Mar. 13, 1990 |
| 4902680 |
Treating central nervous system diseases |
Feb. 20, 1990 |
| 4902681 |
Inhibition of immune clearance using progesterone analogues |
Feb. 20, 1990 |
| 4900477 |
Novel intermediates and an improved process for producing the compound (3.beta.,5.alpha.)-3-hydroxycholest-8(14)-en-15-one |
Feb. 13, 1990 |
| 4898857 |
Treating control nervous system diseases |
Feb. 6, 1990 |
| 4898856 |
Method for treating central nervous system diseases |
Feb. 6, 1990 |
| 4897389 |
Treating central nervous system diseases |
Jan. 30, 1990 |
|
|
|
